|

Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring

RECRUITINGSponsored by The Institute of Molecular and Translational Medicine, Czech Republic
Actively Recruiting
SponsorThe Institute of Molecular and Translational Medicine, Czech Republic
Started2022-06-01
Est. completion2026-05-31
Eligibility
Age18 Years – 99 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05774561

Summary

This trial will evaluate the possible benefits and the performance of liquid biopsies in HPV-associated cancer treatment monitoring. This study aims to find a combination of an adequately sensitive and specific sampling method and biomarkers for early risk stratification of disease recurrence.

Eligibility

Age: 18 Years – 99 YearsHealthy volunteers accepted
Inclusion Criteria:

Women diagnosed with CC/HSIL. Men and women diagnosed with OPC. Patients must agree with study enrollment and must sign study informed consent.

Exclusion Criteria:

No exclusion criteria are set.

Conditions5

CancerCervical CancerCervical DysplasiaHuman Papillomavirus InfectionOropharyngeal Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.